What is the exact half-life of Testosterone Cypionate in Testacyp-250 and what does it mean for dosing?

Testosterone Cypionate in Testacyp-250 carries a half-life of approximately 8 days, meaning serum levels decline by 50% every 8 days after peak concentration. Practically, this allows a once- or twice-weekly injection schedule that maintains stable androgen levels without the frequent injections required by short-acting esters. A Monday/Thursday split is a widely used protocol to minimise serum fluctuation.

How does the release profile of Testosterone Cypionate compare to Testosterone Propionate?

Testosterone Cypionate has a half-life roughly four times longer than Testosterone Propionate (~2-day half-life), so its serum release curve is considerably flatter and more prolonged. Where Propionate demands injections every 1–2 days to sustain elevated testosterone, Cypionate's depot mechanism — driven by its longer aliphatic ester chain — sustains biologically active concentrations for up to 14–16 days post-injection, making Testacyp-250 far more practical for weekly administration schedules.

How long after injecting Testacyp-250 does plasma testosterone reach its peak concentration?

Peak plasma testosterone concentration following intramuscular injection of Testosterone Cypionate is typically reached within 24 to 48 hours. After this peak, gradual esterase-mediated hydrolysis releases free testosterone continuously from the intramuscular oil depot, producing the characteristic extended release profile. This trough-to-peak ratio is one of the reasons Cypionate is preferred in TRT protocols requiring hormonal stability.

Why are 10x1ml single-dose ampoules preferable for Testosterone Cypionate 250mg/ml from a sterility standpoint?

Single-dose ampoules eliminate the contamination risk associated with repeated needle penetration of a rubber septum on multi-dose vials. Each hermetically sealed 1 ml ampoule in Testacyp-250 is a closed, sterile unit — opened once and used immediately — meaning no bacterial ingress between doses. BM Pharmaceuticals validates sterility via LAL endotoxin testing and aseptic fill-finish operations, making each ampoule independently verified.

What are the storage requirements for Testacyp-250 10x1ml ampoules and how does storage affect the oil-based formulation?

Testacyp-250 ampoules should be stored at room temperature (15–25 °C), away from direct light and moisture, in the original packaging to protect the glass from UV degradation. Avoid freezing — cold temperatures can cause the oil carrier to thicken or precipitate, which does not affect potency if the ampoule is warmed to body temperature before injection but can impede smooth administration. Inspect each ampoule visually before use; discard if particulate matter is present. (2) angle_used

Long-Acting Formula

BM Pharmaceuticals

Testacyp-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Name: Testacyp-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals
Brand: BM Pharmaceuticals
SKU: INJ-TCYP-BM-250-003
Price: 38.00 EUR
Availability: InStock

Testacyp-250 is an oil-based injectable testosterone ester in which Testosterone Cypionate at 250 mg/ml is engineered around its extended pharmacokinetic profile — delivering a clinically measurable half-life of approximately 8 days that sustains androgen receptor saturation between injections. Each 1 ml single-dose ampoule provides precise, pre-measured delivery in a hermetically sealed format that eliminates multi-use contamination risk. Quality assurance at BM Pharmaceuticals is built into every production stage: HPLC potency verification, LAL endotoxin screening, and GMP-certified fill-finish operations underpin every released batch.

€38.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Sustained androgen receptor activation across a full week from a single 250 mg dose
Predictable trough-to-peak serum ratio — reducing mood and energy swings between injections
Precisely dosed 1 ml hermetically sealed ampoules — no measurement errors, no multi-use risk
HPLC-verified concentration ensures every ampoule delivers the labelled 250 mg/ml
Compatible with both TRT protocols and performance-oriented cycling regimens
Once- or twice-weekly schedule reduces total injection events compared to short-ester alternatives
GMP-certified, LAL endotoxin-tested batch release — traceable from API sourcing to finished ampoule

Phase	Dosage	Note
Introductory / Sensitivity Assessment	250 mg/week (1 ampoule × 1 injection/week)	Allows the 8-day half-life to establish steady-state serum levels within 3–4 weeks; baseline blood work before starting is recommended.
Maintenance / TRT-Range	125–250 mg/week (split Mon/Thu for twice-weekly dosing)	Splitting the weekly dose exploits the pharmacokinetic profile to flatten the serum curve; each half-dose = 0.5–1 ampoule.
Performance Cycle	500 mg/week (2 ampoules/week, split evenly)	Higher doses extend the time to reach steady-state; given the ~8-day half-life, full steady-state is approached after approximately 4–5 weeks.
Tapering / Pre-PCT	Reduce by 50% in final 2 weeks	Because of the long half-life, the last injection should be timed at least 14–18 days before PCT initiation to allow adequate serum clearance.

Key takeaways

Expect an approximate 8-day half-life supporting weekly injection schedules.
Choose twice-weekly dosing to minimise intra-week serum testosterone fluctuation.
Verify potency confidence: HPLC-confirmed 250 mg/ml per ampoule.
Store ampoules at 15–25 °C and warm before injection if oil has thickened.
Open each single-dose ampoule immediately before use to preserve sterility.

Testosterone Cypionate: Pharmacokinetic Profile as the Defining Feature

Testacyp-250 is a pharmaceutical-grade injectable defined by the slow-release behaviour of its active ester — Testosterone Cypionate at 250 mg/ml — whose long aliphatic side chain controls absorption rate from the intramuscular depot and determines the entire clinical dosing strategy. Compared to shorter esters such as Testosterone Propionate (half-life ~2 days), Testosterone Cypionate maintains biologically active serum testosterone concentrations over a substantially wider window, typically 14–16 days post-injection according to pharmacokinetic modelling referenced in clinical endocrinology literature. This extended exposure is the reason Testacyp-250 carries the Long-Acting Formula designation.

How the Half-Life Shapes the Release Profile

Testosterone Cypionate carries a reported half-life of approximately 8 days, meaning serum testosterone falls by roughly 50% every eight days following peak plasma concentration. The depot mechanism works as follows: after intramuscular injection, the cypionate ester is stored in the oil phase at the injection site, then gradually hydrolysed by plasma esterases into free testosterone, which then binds androgen receptors in target tissues. Peak plasma levels are typically reached 24–48 hours post-injection, establishing a trough-to-peak ratio that is considerably more stable than that produced by short-ester formulations requiring daily or every-other-day administration.

Injection Frequency and Hormonal Stability

The pharmacokinetic data support a once- or twice-weekly injection schedule — most commonly 1–2 administrations per week — to keep serum testosterone within a physiologically elevated band without pronounced peaks and troughs. Twice-weekly dosing (e.g., Monday/Thursday split) further smooths the serum curve and minimises intra-week fluctuation in mood, libido, and recovery markers. BM Pharmaceuticals formulates Testacyp-250 in individual 1 ml ampoules; each ampoule delivers exactly 250 mg Testosterone Cypionate, eliminating measurement error that occurs with multi-dose vials.

Analytical Verification of Potency

BM Pharmaceuticals confirms active-ingredient concentration by HPLC (High-Performance Liquid Chromatography) — the reference method specified in Ph. Eur. monographs — ensuring the stated 250 mg/ml reflects actual content rather than nominal labelling. Batch sterility is verified via LAL (Limulus Amebocyte Lysate) endotoxin testing, and production is conducted under GMP-certified conditions in ISO-classified clean-room environments.

Usage

Timing based on half-life: Plan your injection days around the ~8-day half-life of Testosterone Cypionate — a Monday/Thursday split maintains steadier serum levels than a single weekly injection.
Ampoule preparation: Warm the sealed ampoule briefly between your palms for 30–60 seconds if stored below room temperature, ensuring the oil carrier flows freely before opening.
Sterile opening: Score and snap the ampoule neck using a sterile gauze pad; draw the full 1 ml content immediately using an 18–21 G drawing needle to avoid particulate contamination.
Switch to injection needle: Replace the drawing needle with a fresh 23–25 G, 1–1.5 inch injection needle appropriate for intramuscular administration (glute, vastus lateralis, or deltoid).
Injection technique: Aspirate briefly, inject slowly over 20–30 seconds to minimise post-injection discomfort from the oil volume, then withdraw smoothly and apply gentle pressure with sterile gauze.
Disposal and logging: Discard the used ampoule and needles in a sharps container immediately; log injection site, dose, and date to track your protocol against the pharmacokinetic timeline and schedule blood work at the appropriate steady-state window (week 4–5 at minimum).

Warnings

Contraindications: Testacyp-250 is contraindicated in individuals with known or suspected androgen-sensitive carcinoma of the prostate or breast, hypercalcaemia, nephrotic syndrome, or documented hypersensitivity to Testosterone Cypionate or any component of the oil-based carrier. Not indicated for use in women, particularly during pregnancy or lactation, due to virilisation risk. Paediatric use is contraindicated due to premature epiphyseal closure.

Side_Effects: Elevated haematocrit (erythrocytosis), acne, seborrhoea, accelerated androgenic alopecia, and suppression of endogenous HPG axis function are the most commonly reported effects. Aromatisation to oestradiol may produce gynaecomastia, water retention, and elevated blood pressure in susceptible individuals — an aromatase inhibitor may be required. Injection-site reactions including localised pain and oil granuloma are possible; rotate sites systematically.

Monitoring: Serum testosterone (trough and peak where relevant), haematocrit, haemoglobin, liver enzymes (ALT/AST), lipid panel (LDL/HDL ratio), blood pressure, and PSA (in males over 40) should be assessed at baseline and repeated every 6–12 weeks during active use. Given Testosterone Cypionate's ~8-day half-life, trough samples should be drawn 7 days post-injection for an accurate steady-state reading.

PCT: Endogenous testosterone suppression is dose- and duration-dependent. Due to the extended half-life, PCT should not begin until at least 14–18 days after the final Testacyp-250 injection. Standard recovery protocols incorporate SERMs (e.g., Tamoxifen 20–40 mg/day or Clomiphene 50 mg/day) for 4–6 weeks, with hCG optionally integrated during the final weeks of the cycle to prime Leydig cell function before SERM-based recovery.

Frequently asked questions

What is the exact half-life of Testosterone Cypionate in Testacyp-250 and what does it mean for dosing?: Testosterone Cypionate in Testacyp-250 carries a half-life of approximately 8 days, meaning serum levels decline by 50% every 8 days after peak concentration. Practically, this allows a once- or twice-weekly injection schedule that maintains stable androgen levels without the frequent injections required by short-acting esters. A Monday/Thursday split is a widely used protocol to minimise serum fluctuation.
How does the release profile of Testosterone Cypionate compare to Testosterone Propionate?: Testosterone Cypionate has a half-life roughly four times longer than Testosterone Propionate (~2-day half-life), so its serum release curve is considerably flatter and more prolonged. Where Propionate demands injections every 1–2 days to sustain elevated testosterone, Cypionate's depot mechanism — driven by its longer aliphatic ester chain — sustains biologically active concentrations for up to 14–16 days post-injection, making Testacyp-250 far more practical for weekly administration schedules.
How long after injecting Testacyp-250 does plasma testosterone reach its peak concentration?: Peak plasma testosterone concentration following intramuscular injection of Testosterone Cypionate is typically reached within 24 to 48 hours. After this peak, gradual esterase-mediated hydrolysis releases free testosterone continuously from the intramuscular oil depot, producing the characteristic extended release profile. This trough-to-peak ratio is one of the reasons Cypionate is preferred in TRT protocols requiring hormonal stability.
Why are 10x1ml single-dose ampoules preferable for Testosterone Cypionate 250mg/ml from a sterility standpoint?: Single-dose ampoules eliminate the contamination risk associated with repeated needle penetration of a rubber septum on multi-dose vials. Each hermetically sealed 1 ml ampoule in Testacyp-250 is a closed, sterile unit — opened once and used immediately — meaning no bacterial ingress between doses. BM Pharmaceuticals validates sterility via LAL endotoxin testing and aseptic fill-finish operations, making each ampoule independently verified.
What are the storage requirements for Testacyp-250 10x1ml ampoules and how does storage affect the oil-based formulation?: Testacyp-250 ampoules should be stored at room temperature (15–25 °C), away from direct light and moisture, in the original packaging to protect the glass from UV degradation. Avoid freezing — cold temperatures can cause the oil carrier to thicken or precipitate, which does not affect potency if the ampoule is warmed to body temperature before injection but can impede smooth administration. Inspect each ampoule visually before use; discard if particulate matter is present. (2) angle_used

Manufacturer

BM Pharmaceuticals sources the active pharmaceutical ingredient in Testacyp-250 — Testosterone Cypionate API — through qualified raw-material suppliers subject to documented vendor qualification procedures, including identity testing by IR spectroscopy and purity assessment by HPLC prior to acceptance into production. The incoming API undergoes a formal quarantine-and-release workflow governed by the company's in-house Quality Management System, ensuring that no batch enters the manufacturing stream without a conformance record tied to pharmacopoeial specifications. This upstream focus on API origin and qualification is consistent with the company's GMP framework and reflects an approach where raw-material integrity is treated as a prerequisite — not an afterthought — of injectable product quality.

Product details

Brand	BM Pharmaceuticals
Active ingredient	testosterone cypionate
Also known as	Testosterone Cypionate, Test C, Depo-Testosteronee, Testacyp-250, BM Pharmaceuticals Testosterone Cypionate
Strength	250 mg
Form	Ampullen
Pack size	10 pieces
Item number	INJ-TCYP-BM-250-003

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Cipandrol 200mg/ml 10x1ml Ampoules by Balkan Pharmaceuticals

Established Brand

Cipandrol 200mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

Cipandrol is a pharmaceutical-grade injectable testosterone preparation built around Testosterone Cypionate at 200 mg/ml — a compound whose origins trace back to American clinical research of the 1950s, when chemists at Upjohn first attached the cypionate ester to extend testosterone's therapeutic window. Presented in individual glass ampoules (10 × 1 ml), each unit delivers a precise, single-use dose free from the cross-contamination risk inherent in repeatedly punctured multi-dose vials. Sterility and potency are verified through independent HPLC quantification and LAL endotoxin screening conducted at Balkan Pharmaceuticals' GMP-certified Chișinău facility.

€38.00

High Concentration

Cypo-Testosterone 200mg/ml 10ml Vial by Beligas Pharmaceuticals

Cypo-Testosterone by Beligas Pharmaceuticals is a single-ingredient injectable androgen — Testosterone Cypionate at 200 mg per millilitre in a 10 ml multi-dose vial — engineered specifically to slot into structured, periodised cycle frameworks. At this concentration, each 1 ml draw delivers a precise 200 mg dose, giving cycle planners clean arithmetic when calculating weekly volume across bulking, maintenance, or recomposition phases. Quality assurance is enforced at every stage: HPLC-verified potency, LAL endotoxin testing, and GMP-certified filling conditions underpin every vial released under the Beligas label.

€38.00

Brand Quality

CypioTrex 350mg/ml 10ml Vial by Concentrex Labs

CypioTrex is a high-concentration testosterone cypionate injectable — 350 mg/ml in a 10 ml multi-dose vial — engineered specifically for athletes running structured cruise-and-blast protocols that require distinct, clearly separated androgenic phases. At 350 mg/ml, each millilitre delivers 75% more active compound than standard 200 mg/ml preparations, reducing injection volume while maintaining full dosing flexibility across both the high-output blast window and the lower-dose cruise interval. Every batch is released only after passing in-house HPLC potency verification and LAL endotoxin screening, with GMP-aligned documentation supporting each production stage.

€38.00

Pro Choice

Cypionat 250 250mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma Cypionat 250 is a pharmaceutical-grade injectable testosterone replacement solution delivering 250 mg of Testosterone Cypionate per millilitre, formulated specifically for men seeking sustained hormonal support within a clinical TRT or medically guided anti-aging framework. Its long-acting ester profile supports stable serum testosterone levels across weekly dosing intervals, making it a practical choice for men over 40 managing age-related androgen decline. Every 10 ml vial batch undergoes HPLC potency verification and LAL endotoxin screening prior to release; GMP-compliant production records accompany each lot.

€36.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00